Sanders Responds to FTC’s Efforts to Target ‘Junk’ Ozempic Patents

30 avril 2024 | Newswire Editor
Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, today released the following statement after Federal Trade Commission (FTC) Chair Lina Khan announced that the FTC is taking action against the bogus patents Novo Nordisk filed to keep (...)
 Site référencé:  Common Dreams

Common Dreams 

15 States Enact Laws to Regulate AI Deepfakes in Elections
20/05/2024
Ungaggable : Costumed Clowns and Lickspittle Surrogates 'R Us
18/05/2024
EPA : $1.3 Trillion Needed for Nation’s Water Infrastructure
15/05/2024
The 2024 Class of Gaza : The Students Have Done Their Part
15/05/2024
IRS Should Make Direct File Permanent, Available Nationwide, More Than 250 Groups Said
14/05/2024
Lobbying to Influence Legislation Including Farm Bill Tops $500 Million
13/05/2024